Showing results (281-290 of 370) with videos related to
Sort By:
Pageof 37
The Biochemical Journal|August 15, 1988
The iron chelators desferrioxamine and 1-alkyl-2-methyl-3-hydroxypyrid-4-ones inhibit vascular prostacyclin synthesis in vitroJ Y Jeremy, G J Kontoghiorghes, A V Hoffbrand, et al.The Journal of Clinical Endocrinology and Metabolism|February 1, 1992
Differential changes in alpha- and beta-adrenoceptor linked [45Ca2+] uptake in platelets from patients with anorexia nervosaJ Gill, V DeSouza, A Wakeling, et al.Journal of Human Hypertension|July 2, 2004
Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart diseaseV G Athyros, D P Mikhailidis, A A Papageorgiou, et al.Journal of Clinical Pathology|June 29, 2004
The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) studyV G Athyros, D P Mikhailidis, A A Papageorgiou, et al.Current Medical Research and Opinion|October 7, 2004
The role of cilostazol in the treatment of intermittent claudicationA H Barnett, A W Bradbury, J Brittenden, et al.International Journal of Clinical Practice|March 31, 2007
Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjectsH J Milionis, M S Kostapanos, E N Liberopoulos, et al.Pharmatherapeutica|January 1, 1985
The effect of diflunisal administration on platelet aggregation and cerebral blood flowD P Mikhailidis, M A Barradas, I Temple-Savage, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|November 27, 2009
Effect of a plant stanol ester-containing spread, placebo spread, or Mediterranean diet on estimated cardiovascular risk and lipid, inflammatory and haemostatic factorsV G Athyros, A I Kakafika, A A Papageorgiou, et al.Journal of Clinical Pathology|March 1, 1984
Exocrine pancreatic function in diabetes mellitusP Dandona, D B Freedman, Y Foo, et al.Current Medical Research and Opinion|June 3, 2008
The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemiaE S Nakou, T D Filippatos, M Georgoula, et al.Pageof 37